Optically driven microtools with an antibody-immobilised surface for on-site cell assembly.

IET Nanobiotechnol

Department of Intelligent Mechanical Systems Engineering, Kagawa University, Takamatsu, Japan.

Published: May 2023

AI Article Synopsis

  • The study develops a new method for assembling cells into clusters at a single-cell level using a specially designed microtool in a microfluidic device.
  • The microtool is created with antibodies that bind to specific proteins on the surface of cancer cells, enabling precise capture and assembly of the cells.
  • This platform allows for the efficient creation of cell clusters for applications in regenerative medicine and drug testing, mimicking real tissue and organ behavior.

Article Abstract

To enable the accurate reproduction of organs in vitro, and improve drug screening efficiency and regenerative medicine research, it is necessary to assemble cells with single-cell resolution to form cell clusters. However, a method to assemble such forms has not been developed. In this study, a platform for on-site cell assembly at the single-cell level using optically driven microtools in a microfluidic device is developed. The microtool was fabricated by SU-8 photolithography, and antibodies were immobilised on its surface. The cells were captured by the microtool through the bindings between the antibodies on the microtool and the antigens on the cell membrane. Transmembrane proteins, CD51/61 and CD44 that facilitate cell adhesion, commonly found on the surface of cancer cells were targeted. The microtool containing antibodies for CD51/61 and CD44 proteins was manipulated using optical tweezers to capture HeLa cells placed on a microfluidic device. A comparison of the adhesion rates of different surface treatments showed the superiority of the antibody-immobilised microtool. The assembly of multiple cells into a cluster by repeating the cell capture process is further demonstrated. The geometry and surface function of the microtool can be modified according to the cell assembly requirements. The platform can be used in regenerative medicine and drug screening to produce cell clusters that closely resemble tissues and organs in vivo.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190638PMC
http://dx.doi.org/10.1049/nbt2.12114DOI Listing

Publication Analysis

Top Keywords

cell assembly
12
optically driven
8
driven microtools
8
cell
8
on-site cell
8
drug screening
8
regenerative medicine
8
cell clusters
8
microfluidic device
8
cd51/61 cd44
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!